EGFR and cancer: A literature study employing in silico methods demonstrated that curcumin analogs exhibit significantly better binding affinity to target receptors such as Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Epidermal Growth Factor Receptor (EGFR), which are associated with cancer, compared to curcumin [5].